- Home
- PHAR vs CGNT Comparison
PHAR vs CGNT Comparison
Compare PHAR & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- CGNT
- Stock Information
- Founded
- PHAR 1988
- CGNT 2020
- Country
- PHAR Netherlands
- CGNT Israel
- Employees
- PHAR N/A
- CGNT N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- CGNT Computer Software: Prepackaged Software
- Sector
- PHAR Health Care
- CGNT Technology
- Exchange
- PHAR Nasdaq
- CGNT Nasdaq
- Market Cap
- PHAR 951.7M
- CGNT 617.3M
- IPO Year
- PHAR N/A
- CGNT N/A
- Fundamental
- Price
- PHAR $14.00
- CGNT $7.95
- Analyst Decision
- PHAR Strong Buy
- CGNT Buy
- Analyst Count
- PHAR 3
- CGNT 2
- Target Price
- PHAR $30.00
- CGNT $14.00
- AVG Volume (30 Days)
- PHAR 13.4K
- CGNT 257.2K
- Earning Date
- PHAR 11-06-2025
- CGNT 09-09-2025
- Dividend Yield
- PHAR N/A
- CGNT N/A
- EPS Growth
- PHAR N/A
- CGNT N/A
- EPS
- PHAR N/A
- CGNT N/A
- Revenue
- PHAR $339,836,000.00
- CGNT $376,566,000.00
- Revenue This Year
- PHAR $17.70
- CGNT $15.30
- Revenue Next Year
- PHAR $12.25
- CGNT $11.30
- P/E Ratio
- PHAR N/A
- CGNT N/A
- Revenue Growth
- PHAR 22.44
- CGNT 14.04
- 52 Week Low
- PHAR $7.31
- CGNT $6.38
- 52 Week High
- PHAR $17.08
- CGNT $11.66
- Technical
- Relative Strength Index (RSI)
- PHAR 47.61
- CGNT 39.34
- Support Level
- PHAR $13.96
- CGNT $8.00
- Resistance Level
- PHAR $14.70
- CGNT $8.28
- Average True Range (ATR)
- PHAR 0.55
- CGNT 0.29
- MACD
- PHAR -0.16
- CGNT -0.02
- Stochastic Oscillator
- PHAR 4.25
- CGNT 23.81
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.